Puritan at ECCMID

« Previous article
Distributors of Cher...
Next article »

10th August 2020  Product update: rapidmicrobiology staff writer

New Mouse-Derived Monoclonal Antibodies for COVID-19 Research 

ViroStat has developed and released a set of new monoclonal antibodies to the nucleocapsid of the COVID-19 virus. These final five antibodies were selected from an initial group of 60 based upon highest binding affinity and best ELISA pairing for detection of native viral antigen.

ViroStat believe the nucleocapsid of COVID-19 virus is ideal for antigen detection for these reasons:

  • it is a highly conserved protein and therefore not prone to mutation.
  • It is produced abundantly in the cytoplasm of infected cells
  • These cells can be collected on a nasopharyngeal swab and added to a specimen buffer to lyse and release this antigen for detection by immunoassay.

The set includes Ig class antibodies: IgG2b, IgG1 and IgG. These are specific for the nucleoprotein of COVID-19 for use in ELISA tests. 

These products are for research use only and not for use in diagnostic procedures. 

Share on:


Date Published: 10th August 2020

Source article link: View

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.

View full company details

Visit Booth D37 at ECCMID to meet the MWE Team

Showcasing molecular diagnostic kits for clinical and food labs

Compare Microbiology Products

Water Microbiology a rapidmicrobiology special focus

Watch Webinar

Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!